{
    "2019-08-30": [
        [
            {
                "time": "",
                "original_text": "股基金业绩稳重有升，FOF组合平均超额收益逾3%",
                "features": {
                    "keywords": [
                        "股基金",
                        "业绩",
                        "FOF组合",
                        "超额收益"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:从“中国新”走向“全球新”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "中国新",
                        "全球新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}